A randomized, placebo-controlled, phase IIIb HPV vaccination trial with Gardasil(R) in patients with recurrent condylomata acuminata
Latest Information Update: 10 Jul 2019
Price :
$35 *
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Condylomata acuminata
- Focus Therapeutic Use
- Acronyms GaReCo
- 15 May 2018 Status changed from recruiting to suspended.
- 29 Jul 2014 New trial record